Market Closed -
Other stock markets
|
After market 04:21:38 pm | |||
57.08 USD | +2.13% | 57.44 | +0.64% |
Apr. 18 | Citigroup Adjusts CRISPR Therapeutics' Price Target to $89 From $88, Keeps Buy Rating | MT |
Apr. 17 | Crispr Therapeutics Insider Sold Shares Worth $1,173,232, According to a Recent SEC Filing | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.82% | 4.74B | |
+22.79% | 47.9B | |
+46.56% | 41.42B | |
-1.88% | 40.7B | |
-6.20% | 28.92B | |
+11.39% | 25.55B | |
-21.08% | 19.27B | |
-1.41% | 12.15B | |
+30.52% | 12.14B | |
-0.48% | 11.99B |
- Stock Market
- Equities
- CRSP Stock
- News CRISPR Therapeutics AG
- Transcript : CRISPR Therapeutics AG - Special Call